SCHEMBL1041994

SCHEMBL1041994

O=[C]c1ccc(F)nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740463 0.76
SCHEMBL3071411 0.76
SCHEMBL15541066 0.76
SCHEMBL456126 0.76
SCHEMBL29413240 0.76
SCHEMBL11776219 0.73 GRM5 (0.33)
SCHEMBL15516427 0.73 GRM5 (0.49)
SCHEMBL16482920 0.73 GRM5 (0.53)
SCHEMBL24811641 0.73 GRM5 (0.45)
SCHEMBL2445812 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109476655-B Carbonic anhydrase IX-targeted nuclear imaging and radiotherapy agents and uses thereof 约翰霍普金斯大学 2022-03-08 CN disclosed
EP-3455222-B1 NUCLEAR IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING CARBONIC ANHYDRASE IX AND USES THEREOF UNIV JOHNS HOPKINS (US) 2022-03-02 EP disclosed
US-10857246-B2 Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase IX and uses thereof THE JOHNS HOPKINS UNIVERSITY (US) 2020-12-08 US disclosed
US-20190192699-A1 NUCLEAR IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING CARBONIC ANHYDRASE IX AND USES THEREOF THE JOHNS HOPKINS UNIVERSITY 2019-06-27 US disclosed
EP-3455222-A1 NUCLEAR IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING CARBONIC ANHYDRASE IX AND USES THEREOF The Johns Hopkins University (US) 2019-03-20 EP disclosed
US-20180133348-A1 NUCLEAR IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING CARBONIC ANHYDRASE IX AND USES THEREOF THE JOHNS HOPKINS UNIVERSITY 2018-05-17 US disclosed
WO-2017197251-A1 NUCLEAR IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING CARBONIC ANHYDRASE IX AND USES THEREOF THE JOHNS HOPKINS UNIVERSITY (US) 2017-11-16 WO disclosed
WO-2016196628-A1 NUCLEAR IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING CARBONIC ANHYDRASE IX AND USES THEREOF THE JOHNS HOPKINS UNIVERSITY (US) 2016-12-08 WO disclosed
EP-2635571-B1 NOVEL INHIBITORS OF HEPATITIS C VIRUS THERAVANCE BIOPHARMA R & D IP LLC (US) 2015-08-12 EP disclosed
US-20140051689-A1 Polycyclic Agents for the Treatment of Respiratory Syncytial Virus Infections BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) 2014-02-20 US disclosed
US-8598193-B2 Polycyclic agents for the treatment of respiratory syncytial virus infections BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) 2013-12-03 US disclosed
EP-2287167-A1 Polycyclic agents for the treatment of respiratory syncytial virus infections BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) 2011-02-23 EP disclosed
EP-1697377-B1 POLYCYCLIC AGENTS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS BIOTA SCIENT MANAGEMENT (AU) 2011-01-26 EP disclosed
US-20100233415-A1 OPTICAL RECORDING MEDIUM AND AZO METAL CHELATE COMPOUND MITSUI CHEMICALS, INC. (JP) 2010-09-16 US disclosed
EP-1997856-A1 OPTICAL RECORDING MEDIUM AND AZO METAL CHELATE COMPOUND Mitsui Chemicals, Inc. (JP) 2008-12-03 EP disclosed
EP-1697377-A4 POLYCYCLIC AGENTS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS BIOTA SCIENT MANAGEMENT (AU) 2008-03-19 EP disclosed
US-20070287700-A1 Polycyclic agents for the treatment of respiratory syncytial virus infections BIOTA SCIENTFIC MANAGEMENMT PTY LTD. (AU) 2007-12-13 US disclosed
EP-1697377-A1 POLYCYCLIC AGENTS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS BIOTA SCIENTIFIC MANAGEMENT PTY. LTD. (AU) 2006-09-06 EP disclosed
WO-2005061513-A1 POLYCYCLIC AGENTS FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS INFECTIONS BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) 2005-07-07 WO disclosed